|
1.
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
3.
|
Louvet C, Labianca R, Hammel P, et al:
Gemcitabine in combination with oxaliplatin compared with
gemcitabine alone in locally advanced or metastatic pancreatic
cancer: results of a GERCOR and GISCAD phase III trial. J Clin
Oncol. 23:3509–3516. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Heinemann V, Quietzsch D, Gieseler F, et
al: Randomized phase III trial of gemcitabine plus cisplatin
compared with gemcitabine alone in advanced pancreatic cancer. J
Clin Oncol. 24:3946–3952. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Herrmann R, Bodoky G, Ruhstaller T, et al:
Gemcitabine plus capecitabine compared with gemcitabine alone in
advanced pancreatic cancer: a randomized, multicenter, phase III
trial of the Swiss Group for Clinical Cancer Research and the
Central European Cooperative Oncology Group. J Clin Oncol.
25:2212–2217. 2007. View Article : Google Scholar
|
|
6.
|
Burris HA III, Moore MJ, Andersen J, et
al: Improvements in survival and clinical benefit with gemcitabine
as first-line therapy for patients with advanced pancreas cancer: a
randomized trial. J Clin Oncol. 15:2403–2413. 1997.PubMed/NCBI
|
|
7.
|
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi
AS, Kong D and Sarkar FH: Pancreatic cancer: understanding and
overcoming chemoresistance. Nat Rev Gastroenterol Hepatol. 8:27–33.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Hsu YL, Yen MH, Kuo PL, et al:
San-Zhong-Kui-Jian-Tang, a traditional Chinese medicine
prescription, inhibits the proliferation of human breast cancer
cells by blocking cell cycle progression and inducing apoptosis.
Biol Pharm Bull. 29:2388–2394. 2006. View Article : Google Scholar
|
|
9.
|
Yang CH and Craise LM: Development of
human epithelial cell systems for radiation risk assessment. Adv
Space Res. 14:115–120. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Cheng CY, Lin YH and Su CC:
Sann-Joong-Kuey-Jian-Tang increases the protein expression of
microtubule-associated protein II light chain 3 in human colon
cancer colo 205 cells. Mol Med Rep. 2:707–711. 2009.PubMed/NCBI
|
|
11.
|
Cheng CY, Lin YH and Su CC:
Sann-Joong-Kuey-Jian-Tang up-regulates the protein expression of
Fas and TNF-α in colo 205 cells in vivo and in vitro.
Mol Med Rep. 3:63–67. 2010.PubMed/NCBI
|
|
12.
|
Chen YL, Yan MY, Chien SY, Kuo SJ, Chen
DR, Cheng CY and Su CC: Sann-Joong-Kuey-Jian-Tang inhibits
hepatocellular carcinoma Hep-G2 cell proliferation by increasing
TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and
Mcl-1 expression in vitro. Mol Med Rep. 7:1487–1493.
2013.PubMed/NCBI
|
|
13.
|
Carswell EA, Old LJ, Kassel RL, et al: An
endotoxin-induced serum factor that causes necrosis of tumors. Proc
Natl Acad Sci USA. 72:3666–3670. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gaur U and Aggarwal BB: Regulation of
proliferation, survival and apoptosis by members of the TNF
superfamily. Biochem Pharmacol. 66:1403–1408. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yenofsky R, Cereghini S, Krowczynska A and
Brawerman G: Regulation of mRNA utilization in mouse
erythroleukemia cells induced to differentiate by exposure to
dimethyl sulfoxide. Mol Cell Biol. 3:1197–1203. 1983.PubMed/NCBI
|
|
16.
|
Chitpatima ST, Makrides S, Bandyopadhyay R
and Brawerman G: Nucleotide sequence of a major messenger RNA for a
21 kilo-dalton polypeptide that is under translational control in
mouse tumor cells. Nucleic Acids Res. 16:23501988. View Article : Google Scholar
|
|
17.
|
Bommer UA, Lazaris-Karatzas A, De
Benedetti A, et al: Translational regulation of the mammalian
growth-related protein P23: involvement of eIF-4E. Cell Mol Biol
Res. 40:633–641. 1994.PubMed/NCBI
|
|
18.
|
Bommer UA and Thiele BJ: The
translationally controlled tumour protein (TCTP). Int J Biochem
Cell Biol. 36:379–385. 2004. View Article : Google Scholar
|
|
19.
|
Zhang D, Li F, Weidner D, et al: Physical
and functional interaction between myeloid cell leukemia 1 protein
(MCL1) and Fortilin. The potential role of MCL-1 as a fortilin
chaperone. J Biol Chem. 277:37430–37438. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Graidist P, Phongdara A and Fujise K:
Antiapoptotic protein partners fortilin and MCL1 independently
protect cells from 5-fluorouracil-induced cytotoxicity. J Biol
Chem. 279:40868–40875. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Liu H, Peng HW, Cheng YS, et al:
Stabilization and enhancement of the antiapoptotic activity of
mcl-1 by TCTP. Mol Cell Biol. 25:3117–3126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Susini L, Besse S, Duflaut D, et al: TCTP
protects from apoptotic cell death by antagonizing bax function.
Cell Death Differ. 15:1211–1220. 2008. View Article : Google Scholar : PubMed/NCBI
|
